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Abstract
Age‐related tendon degeneration (tendinosis) is characterized by a phenotypic
change in which tenocytes display characteristics of fibrochondrocytes and mineral-
ized fibrochondrocytes. As tendon degeneration has been noted in vivo in areas of
decreased tendon vascularity, we hypothesized that hypoxia is responsible for the
development of the tendinosis phenotype, and that these effects are more pro-
nounced in aged tenocytes. Hypoxic (1% O2) culture of aged, tendinotic, and young
human tenocytes resulted in a mineralized fibrochondrocyte phenotype in aged
tenocytes, and a fibrochondrocyte phenotype in young and tendinotic tenocytes.
Investigation of the molecular mechanism responsible for this phenotype change
revealed that the fibrochondrocyte phenotype in aged tenocytes occurs with
decreased Rac1 activity in response to hypoxia. In young hypoxic tenocytes, how-
ever, the fibrochondrocyte phenotype occurs with concomitant decreased Rac1
activity coupled with increased RhoA activity. Using pharmacologic and adenoviral
manipulation, we confirmed that these hypoxic effects on the tenocyte phenotype
are linked directly to the activity of RhoA/Rac1 GTPase in in vitro human cell culture
and tendon explants. These results demonstrate that hypoxia drives tenocyte phe-
notypic changes, and provide a molecular insight into the development of human
tendinosis that occurs with aging.
K E YWORD S
fibrochondrocyte, hypoxia, Rac1, RhoA, tendinosis, tenocyte
1 | INTRODUCTION
Tendinosis—degenerative tendon injury—predominantly affects the
elderly and results in significant medical costs and disability. Tendi-
nosis is detected histologically by altered cellularity, vasculature, and
changes in the tenocyte phenotype (Maffulli, Wong, & Almekinders,
2003). While it is well known that tendon vascularity decreases with
age, the molecular etiology for tendinosis development remains
unclear. Normally, tendons are composed of tenocytes, elongated
fibroblasts located in tendon (Kannus, 2000), that are derived from
mesenchymal stem cells (Maharam et al., 2015). Cells in diseased
tendon, however, commonly exhibit a fibrocartilaginous phenotype
and display a hyaline, mucoid, calcified, or fibrous appearance (Kan-
nus & Jozsa, 1991). Interestingly, these same histologic changes
noted in tendinosis tissue of elderly patients have also been noted
to a lesser extent in tendons of asymptomatic aged individuals, sug-
gesting that tendinosis results from sustained cellular responses to
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cues that exist physiologically in the aging tenocyte microenviron-
ment.
One explanation for the altered cell phenotype observed in aged
tendon is that human tenocytes develop a fibrochondrocyte phenotype
depending on their microenvironment, in particular to changes in oxy-
gen level effected by tendon vascularity. Tendon vascularity decreases
with age (Brewer, 1979) and tendinosis increases in hypovascular areas
of tendon (Millar et al., 2012). In vitro, the environmental oxygen ten-
sion has previously been considered as key to cell survival, while other
studies have linked the importance of oxygen tension to maintenance
of the tenocyte phenotype (Fehrer et al., 2007; Zhang & Wang, 2018).
We hypothesize that the decreased vascularity of tendon that occurs
with aging affects tenocyte metabolic and other intracellular signaling
pathways, thus influencing the cellular phenotype.
Another explanation for the development of the tendinosis pheno-
type concerns the connective tissue mechanical environment, namely
force transmission. Tendinosis has long been associated with repeti-
tive use and mechanical overload as well as age (Yamaguchi et al.,
2006). Studies of human tissues as well as animal models demonstrate
a fibrochondrocyte phenotype—tenocyte rounding and collagen II
secretion—in tendons exposed to an increased compressive mechani-
cal force (Benjamin, Qin, & Ralphs, 1995). Signaling cascades involved
in force transmission include the Rho/Rac GTPases. Rac1 is activated
by tensile stretch, while RhoA is activated by compression (Hauden-
schild, Nguyen, Chen, D'Lima, & Lotz, 2008; Katsumi et al., 2002).
Rho/Rac GTPases are not exclusively force‐activated: Rac1 and RhoA
are also activated by hypoxia (Hirota & Semenza, 2001; Turcotte, Des-
rosiers, & Beliveau, 2003). It has previously been shown at the cellular
level that force transmission through the RhoA/Rac1 GTPases is criti-
cal to other connective tissue cell phenotypes (McBeath, Pirone, Nel-
son, Bhadriraju, & Chen, 2004; Gao, McBeath, & Chen, 2010; Woods,
Wang, Dupuis, Shao, & Beier, 2007). We hypothesize here that the
change in tenocyte phenotype in aging tendon is due to altered RhoA/
Rac1 signaling in a hypoxic microenvironment.
To test the hypothesis that the tendinosis phenotype is dependent
on oxygen tension and mediated by changes in RhoA/Rac1 GTPase
activity, we examined collagen production and calcification in aged
tendinotic and young asymptomatic tendon tissue via Fourier‐trans-
form infrared spectroscopy (FTIR). Aged diseased tendon tissue dis-
played decreased mature collagen and increased calcification as
compared to young asymptomatic tendon tissue. Similarly, when aged
tenocytes were cultured in vitro, we found that aged tenocytes calci-
fied in hypoxia but not normoxia. Furthermore, hypoxia resulted in a
fibrochondrocyte phenotype in all cell types in a density‐dependent
manner. Investigation of the signaling mechanism during this transition
revealed the fibrochondrocyte phenotype in aged tenocytes occurred
with decreased Rac1 activity. In young hypoxic tenocytes, the fibro-
chondrocyte phenotype occurred with concomitantly decreased Rac1
activity coupled with increased RhoA activity. We confirmed that this
hypoxic effect on the human tenocyte phenotype was linked directly
to the activity of RhoA/Rac1 GTPase via pharmacologic and adenoviral
manipulation in in vitro human cell culture and tendon explants. These
results demonstrate that hypoxia drives transition of the human
tenocyte to a fibrochondrocyte phenotype, and provide a molecular
insight into the development of human tendinosis.
2 | RESULTS
2.1 | Aged and diseased tendon display altered
cellular morphology and extracellular matrix
production in vivo
In surgical management of tendinosis, we have often observed ten-
don flattening and fraying in older affected individuals (Figure 1a), a
thickened, bulbous appearance in younger affected individuals (Fig-
ure 1b) as compared to a striated, glassy gross tendon phenotype
in young asymptomatic individuals (Figure 1c). Histologic evaluation
reveals changes in the tenocyte phenotype in diseased tendon. In
aged and young diseased tendon, tenocytes are round and sur-
rounded by increased matrix metachromasia (Figure 1d,e), with
areas of calcification (Figure 1g,h). Immunohistochemical staining of
these areas reveals expression of collagen 1α2 (Figure 1j,k) but also
fibrochondrocyte marker collagen 2α1 (Figure 1m,n), and mineral-
ized fibrochondrocyte marker collagen X (Figure 1p,q). Interestingly,
these areas correlate with hypoxia‐inducible factor 1α (HIF‐1α)
expression, the highest levels of which are noted in the diseased
tendon midsubstance, co‐localizing with the fibrochondrocyte and
mineralized fibrochondrocyte phenotype (Figure 1s,t). In contrast,
young asymptomatic tenocyte nuclei are flat, surrounded by stream-
lined collagenous matrix and no calcification (Figure 1f,i), express
collagen 1α2 (Figure 1l) but not collagen 2α1, collagen X, or HIF‐1α
(Figure 1o,r,u). Thus, in aged and young diseased tendon, we have
noted a fibrocartilage and mineralized fibrocartilage phenotype in
areas of tendon compression and fraying, correlating with HIF‐1α
expression.
We subsequently investigated the molecular nature of the gross
phenotypic changes observed in diseased tendon via immunoblot
and FTIR. While asymptomatic tendon is composed almost exclu-
sively of collagen I, aged diseased tendon demonstrated decreased
collagen I and increased collagen II production by immunoblot quan-
titation (Figure 1v). Similarly, FTIR of aged diseased tendon revealed
decreased mature collagen production and increased mineralization
in comparison with young asymptomatic tendon (Figure 1w,x). We
concluded based on these observations that human tendinosis
in vivo is characterized by the development of a fibrochondrocyte
and mineralized fibrochondrocyte phenotype, as demonstrated by
gross morphology, histopathology, immunohistochemistry, protein,
and molecular studies.
2.2 | Aged tenocytes display altered cellular
morphology and extracellular matrix production
in vitro
Given the changes in tenocyte morphology and matrix production
we observed in aged diseased tendon in vivo, we asked whether
these changes exist in in vitro human tenocyte culture and if so,
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what factors are responsible for initiation of the altered phenotype.
First, we isolated tenocytes from young patients undergoing debride-
ment for tendinosis (<45 years, “Tendinotic”), as well as from asymp-
tomatic young (<45 years, “Young”) and aged (>65 years, “Aged”)
patients undergoing revision amputation for irreparable hand injury
according to IRB‐approved and established protocols (Yao, Bestwick,
Bestwick, Maffulli, & Aspden, 2006; Supporting Information Data
S1). As tendinosis is noted in areas of altered vascularity and
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F IGURE 1 Aged and diseased tendon display altered cellular morphology and extracellular matrix production in vivo. (a–c) Intra‐operative
photographs of (a) 84‐year‐old female patient undergoing fibrocartilage pulley release for recalcitrant flexor tendinosis (aged), (b) 42‐year‐old
female patient undergoing tendinosis excision prior to reconstruction (tendinosis), (c) 30‐year‐old female patient undergoing primary tendon
repair after acute laceration (young). Forcep tip delineates the flexor tendon. (d–f) Alcian blue (AB) histopathologic staining of (a‐c),
respectively. Bar = 20 μm. (g–i) Alizarin red (AR) histopathologic staining of (a‐c), respectively. Bar = 20 μm. (j–u) Immunohistochemical staining
of aged (j,m,p,s), tendinosis (k,n,q,t), and young (l,o,r,u) patient samples as in (a–c) for: col1α2 (j‐l), col2α1 (m–o), colX (p–r) and HIF‐1α (s–u).
Bar = 20 μm. (v) Quantitation of immunoblot of collagen 1α2 and collagen 2α1 expression from young asymptomatic tendon (Young) or aged
diseased tendon (Aged). *p < 0.05, n = 4. (w, x) FTIR of young asymptomatic tendon (Young) or aged diseased tendon (Aged tendinotic). (w)
Protein:collagen ratio. (x) Mineral:collagen ratio. Spectrophotometric absorbance as shown below quantitation with absorbance scale to the
right. *p < 0.05, n = 4
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cellularity, we investigated the impact of environmental conditions—
oxygen tension and cell density—on the tenocyte phenotype over
time via qRT–PCR of extracellular matrix proteins found predomi-
nantly in tendon (collagen Iα2, collagen III, tenomodulin), as well as
fibrocartilage (collagen IIα1), and mineralized fibrocartilage (collagen
X) (Figure 2).
Cell shape varied between aged, young tendinotic, and asymp-
tomatic young cells cultured in hypoxic (1% O2) versus normoxic
(21% O2) conditions (Figure 2a–f). Aged tenocytes were consistently
cuboidal, while young tendinotic and asymptomatic young tenocytes
more elongated. Hypoxia resulted in cell rounding in both aged and
young tenocytes. Interestingly, at low cell density in aged hypoxic
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F IGURE 2 Aged tenocytes display altered cellular morphology and extracellular matrix production in vitro. Human tenocytes from aged
(Aged), young tendinotic (Tendinotic), and young asymptomatic (Young) patients were cultured at low (1k/cm2 aged a‐b; 5k/cm2 young
tendinotic c, d and young e, f) cell densities in hypoxic (1% O2; a, c, e) or normoxic conditions (21% O2; b, d, f) over twelve weeks. Shown are
phase contrast micrographs of representative cells from week 2 (wk2), week 8 (wk8), and week 12 (wk12). Bar = 50 μm. (g–j) Brightfield
photomicrographs of alizarin red stained aged (g, h) or young asymptomatic (i, j) tenocytes in hypoxic (1% O2, g, i) or normoxic (21% O2, h, j)
conditions at week 12. (k) Spectrophotometric quantitation of calcification (mg/dL) as detected by alizarin red staining of aged (Aged) or young
asymptomatic (Young) tenocytes cultured in hypoxic (Hypoxia, 1% O2) or normoxic (Normoxia, 21% O2) conditions at low (Low, 1k/cm
2 for
aged, 5k/cm2 for young asymptomatic) or high (High, 25k/cm2 for aged, 50k/cm2 for young asymptomatic) cell densities and harvested at
week 12 in culture. *p < 0.05, n = 4 (l–q) qRT–PCR expression of aged (red), young tendinotic (green), or young asymptomatic (blue) tenocyte
(C1, Scl, Tm, C3), fibrochondrocyte (C2), and mineralized fibrochondrocyte (CX) markers over a 12‐week timecourse, hypoxic (1% O2) as
compared to normoxic (21% O2) conditions, at cell densities: 1k = 1 × 10
3cells/cm2; 5k = 5 × 103 cells/cm2; 25k = 25 × 103 cells/cm2;
50k = 50 × 103cells/cm2 (not available for aged tenocytes). C1 = col1α2; C2 = col2α1; C3 = col3; CX = colX; Scl = scleraxis; Tm = tenomodulin
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tenocytes, we observed the development of prominent extracellular
calcification by week 8, staining positively with Alizarin Red at week
12 (Figure 2g,k) in a density‐dependent manner (Figure 2k). In con-
trast, there was no mineral deposition by young hypoxic tenocytes,
or aged or young normoxic tenocytes (Figure 2h,i,j).
Given the effect of cellularity on matrix mineralization in aged
tenocytes, we then asked how hypoxia and cell density affected the
expression of other extracellular matrix proteins. qRT–PCR of aged,
young tendinotic, and young asymptomatic tenocytes in hypoxic com-
pared to normoxic conditions revealed that hypoxia decreased colla-
gen 1α2 expression in all cell types (Figure 2l); however, hypoxia
increased collagen IIα1 expression in young tendinotic and asymp-
tomatic young tenocytes (Figure 2m) and increased collagen X expres-
sion in all cell types (Figure 2o). The effect of hypoxia was density‐
dependent, with greatest increases in collagen II in young tendinotic
cells at high densities, and collagen X in aged tenocytes at low cell
density (Figure 2m,o). Statistical analysis using Spearman's rho
revealed significant correlations between collagen II and tenomodulin
expression in young asymptomatic tenocytes (p < 0.001); collagen II,
collagen X, and tenomodulin expression in young tendinotic tenocytes
(p < 0.001); and collagen II and collagen X expression in aged teno-
cytes (p < 0.001) (Supporting Information Data S2).
As tendon tissue contains mature tenocytes as well as a small per-
centage (1%–3%) of tenocyte stem cells (Bi et al., 2007), we defined
our cell population using FACS analysis and immunoblot for markers
of stemness (Lui, 2015) (Supporting Information Data S2A) to exclude
the possibility of our growth conditions causing tenocyte stem cell dif-
ferentiation to a fibrochondrocyte phenotype. Supporting Information
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F IGURE 2 Continued
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Data S2A demonstrates that human aged and young tenocytes have
similar FACS profiles, both being positive for CD44, CD73, and CD90
and negative for stem cell markers CD19, CD34, CD45, and CD105.
For both the aged and young human tenocyte populations, immuno-
blot of stem cell markers Oct‐4 and nucleostemin was negative (Sup-
porting Information Data S2B). These findings indicate that the human
cell populations were homogenous, composed of mature tenocytes
and free of significant numbers of stem cells, furthering our observa-
tions that the altered phenotypic changes we observed were in
mature tenocytes, not tenocyte stem cells.
2.3 | Hypoxia regulates the aged tenocyte
phenotype via modulating Rac1 Activity
Interested in the signaling mechanism responsible for the hypoxia‐
driven phenotype changes observed in our tenocyte populations, we
next asked whether changes in RhoA/Rac1 signaling underlied extra-
cellular matrix production by aged, young tendinotic and young
asymptomatic tenocytes in hypoxic (1% O2) and normoxic (21% O2)
conditions. We observed stark differences between aged and young
tenocytes in hypoxia at early timepoints, in that aged tenocytes dis-
played minimal Rac1 activation in hypoxia, but over 12‐fold
increased Rac1 activation in normoxic conditions (21% O2) (Fig-
ure 3a). This hypoxia‐dependent decrease in Rac1 activity in aged
tenocytes occurred concurrently with increased fibrochondrocyte
and mineralized fibrochondrocyte molecular marker expression, colla-
gen IIα1 and collagen X via Spearman's rho analysis (Figure 2m,o;
Supporting Information Data S3). Also, this hypoxia‐dependent
decrease in Rac1 activity in aged tenocytes appeared density‐depen-
dent, as culture of aged tenocytes at high cell density in hypoxia
resulted in increased Rac1 activity (Supporting Information Data
S3A).
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F IGURE 3 Hypoxia regulates the aged tenocyte phenotype via modulating Rac1 Activity. Human tenocytes from aged (a, d) young
tendinotic (b, e) and young asymptomatic (c, f) patients were cultured at low density (aged at 1 × 103 cells/cm2; young tendinotic and young
asymptomatic at 5 × 103 cells/cm2) in hypoxia (1% O2; (H)) or normoxia (21% O2; (n)) over twelve weeks and assayed for Rac1 (a, b, c) and
RhoA (c, d, e) activity. Immunoblots were quantitated using ImageJ software. Error bars = SEM. n = 3. Representative Western blots as shown
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F IGURE 4 Rac1 inactivation modulates the aged tenocyte phenotype. Human tenocytes from aged patients were cultured in hypoxic (1%
O2) or normoxic (21% O2) conditions in the presence or absence of Rac1 inhibitor NSC23766. Tenocytes were harvested after one week and
stained for col1α2 (a–d), col2α1 (e–h) or col3 (i–l) expression via immunofluorescence. Bar = 50 μm. (m–p) Aged, young tendinotic, and young
asymptomatic tenocytes were cultured in hypoxic (1% O2) or normoxic (21% O2) conditions in the presence (NSC) or absence (no drug) of
Rac1 inhibitor NSC23766, harvested after one week and analyzed via qRT–PCR for col1α2 (m), col2α1 (n), col3 (o), or colX (p) expression. Error
bars = SEM, n = 4. *p < 0.05
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With respect to RhoA signaling, both aged and young tenocytes
displayed low RhoA expression and activity in hypoxic and normoxic
conditions at early timepoints (Figure 3d,f). In contrast, young tendi-
notic cells displayed increased RhoA activity in normoxic conditions
compared to aged and young tenocytes (Figure 3e). Also, young
hypoxic tenocytes displayed dramatically increased RhoA activity at
later timepoints weeks 8 and 10 (Figure 3f) which correlated with
decreased Rac1 activity (Figure 3c). This period of decreased Rac1
activity also correlated with increased fibrochondrocyte and mineral-
ized fibrochondrocyte molecular marker expression, collagen IIα1 and
collagen X (Figure 2m,o). Statistical analysis noted correlations
between Rac1 activity and collagen IIα1 expression in aged and
young tenocytes, as well as between Rho activity and collagen X
expression at high cell densities (Supporting Information Data S4).
Aged tenocytes, however, displayed increased RhoA activity at late
timepoint week 12 (Figure 3d), independent of Rac1 activation and
oxygen tension (Figure 3a).
These hypoxia‐dependent decreases in Rac1 activity, occurring
concurrently with increased fibrochondrocyte and mineralized fibro-
chondrocyte markers, suggested that decreased Rac1 activity may be
key to the tenocyte development of a fibrochondrocyte phenotype
in aged cells. Furthermore, these results indicated that in young cells,
decreased Rac1 activity concurrently with increased RhoA activity
underlies tenocyte development of the fibrochondrocyte phenotype.
2.4 | Rac1 inactivation modulates the aged
tenocyte phenotype
Given the early decreased Rac1 activation noted in hypoxia in aged
tenocytes (Figure 3a) and late decreased Rac1 activation in young
tenocytes (Figure 3c), both corresponding with increased fibrochon-
drocyte markers (Figure 2m,o), we next examined the effect of Rac1
inactivation on the aged, tendinotic, and young tenocyte phenotype
using the Rac1 inhibitor, NSC23766 (Gao, Dickerson, Guo, Zheng, &
Zheng, 2004). Aged, young tendinotic, and young asymptomatic
tenocytes were plated at low cell density and cultured in hypoxia
(1% O2) or normoxia (21% O2) in the presence (NSC) or absence
(control) of NSC23766 and analyzed by immunofluorescence and
qRT–PCR (Figure 4). Qualitatively, aged hypoxic tenocytes expressed
more collagen IIα1 (Figure 4e) and collagen III (Figure 4i) than aged
normoxic tenocytes (Figure 4g,k). When treated with NSC23766,
aged hypoxic tenocytes displayed changes in cell shape, as seen by
increased cell rounding, as well as increased expression of collagen
IIα1 and collagen III (Figure 4f,j). Interestingly, these NSC‐dependent
increases in collagen IIα1 and collagen III were not observed in aged
normoxic tenocytes (Figure 4h,l), suggesting that the cue required
for the development of a fibrochondrocyte phenotype is dependent
on Rac1 inactivation in a hypoxic environment.
These effects of hypoxia on fibrochondrocyte marker expression
in aged tenocytes treated with NSC23766 were quantitated via
qRT–PCR and compared to the analogous normoxic condition (21%
O2) (Figure 4m,n,o,p). We found that Rac1 inhibition in aged hypoxic
tenocytes resulted in increased collagen IIα1 (Figure 4n, p < 0.05)
and collagen X (Figure 4p, p < 0.05) as compared to the normoxic
condition. When examining the effects of hypoxia on fibrochondro-
cyte marker expression in young tendinotic and asymptomatic teno-
cytes (Figure 4), we also found Rac1 inhibition resulted in large
increases in collagen IIα1 (Figure 4n, p < 0.05) and collagen X (Fig-
ure 4p, p < 0.05) as compared to the normoxic condition. These
findings suggest that the effects of Rac1 inhibition result in tenocyte
development of a fibrochondrocyte phenotype regardless of cell
type, in hypoxic conditions.
2.5 | Differential, coordinated Rac1 and RhoA
activity direct the human tenocyte phenotype
Given the observation that Rac1 inhibition in hypoxia caused the
fibrochondrocyte phenotype regardless of cell type (Figure 4m–p),
but that RhoA activity differed in aged, young tendinotic versus
young asymptomatic tenocytes (Figure 3d–f), we were interested in
investigating the effect of hypoxia on RhoA activation in those cells
treated with or without the Rac1 inhibitor (Figure 5a). In young
asymptomatic cells, hypoxia resulted in minimal RhoA activation,
which increased 30‐fold in the presence of concomitant Rac1 inhibi-
tion (Figure 5a). This result suggested that a role of hypoxia in teno-
cyte development of the fibrochondrocyte phenotype is in RhoA
activation. This observation, coupled with the reciprocal pattern of
Rac1/RhoA activation in young asymptomatic tenocytes in hypoxia,
and loss of this pattern in aged and young tendinotic tenocytes (Fig-
ure 3), inspired the hypothesis that differential and coordinated
Rac1/RhoA activity is necessary for tenocyte development of the
fibrochondrocyte and mineralized fibrochondrocyte phenotype.
F IGURE 5 Differential, coordinated Rac1 and RhoA activity direct the human tenocyte phenotype. (a) Immunoblot of RhoA activity in
young tenocytes at low density (5 × 103 cells/cm2) cultured in normoxic (n; 21% O2) or hypoxic (H; 1% O2) conditions, without or with Rac1
inhibitor NSC23766 (NSC) harvested after one week. Error bars = SEM, n = 4. *p < 0.05. Representative blot shown. (b–e) Young tenocytes
cultured in normoxic conditions (21% O2) at low (5 × 10
3cells/cm2), medium (25 × 103 cells/cm2), and high (50 × 103 cells/cm2) cell densities
in the absence of drug (no drug), presence of ROCK inhibitor Y‐27632 (Y27), Rac1 inhibitor NSC23766 (NSC), dominant negative Rac1 (RacN),
or RhoA (RhoN), constitutively active Rac1 (RacL), or RhoA (RhoL), without or with ROCK inhibitor Y‐27632 (/Y27) or Rac1 inhibitor
NSC23766 (/NSC). Tenocytes were harvested after one week and analyzed for col1α2 (b), col3 (c), col2α1 (d), or colX (e) expression via qRT–
PCR. Error bars = SEM, n = 4. ***p < 0.001. (f–q) Brightfield photomicrographs of young asymptomatic (“Young,” f–i) young tendinotic (“Tend,”
j–m) or aged (“Aged,” n‐q) human tenocytes cultured in hypoxic (1% O2; (H)) or normoxic (21% O2) conditions in the presence (NSC) or
absence of Rac1 inhibitor NSC23766, and harvested after one week for acid βgalactosidase senescence assay. Bar = 50 μm. (r) Quantitation of
βgalactosidase‐positive staining cells as in (f–q) at time of harvest. Error bars = SEM, n = 4. *p < 0.05
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F IGURE 6 Rac1 inhibition in human tendon explants recreates the aged diseased tendon phenotype. Young diseased tendon (“Tendinotic,”
a, b, j, k) or asymptomatic (“Young,” c–h, l–o) tendon explants cultured in normoxic conditions (21% O2; a, c, j, l), normoxic conditions with
Rac1 inhibitor NSC23766 (NSC, b, d, k, m), hypoxia (1% O2; e, n), or hypoxia with NSC23766 (f, g, h, o) harvested after three months, stained
for H&E (a–h) or via immunohistochemistry (j–o) for col1α2 (C1), col2α1 (C2), colX (CX), or HIF‐1α (HIF1α). Magnification of explants at 4x
after routine H&E staining, with close‐up at 10x. Bar = 20 μm. n = 4. Representative explants shown. (i, j) FTIR of protein:collagen ratio (i) or
mineral:collagen ratio (j) of explants as above. Error bars = SEM, n = 4. *p < 0.05
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To investigate this hypothesis, we used constitutively active and
dominant negative forms of Rac1 and RhoA GTPase in addition to
pharmacologic inhibitors of Rac1 (NSC23766) and Rho‐kinase
(ROCK, Y‐27632), to infect young normoxic (21% O2) tenocytes for
one week prior to harvest for qRT–PCR analysis of tenocyte, fibro-
chondrocyte, and mineralized fibrochondrocyte markers. To observe
whether there was an effect of cell density on the tenocyte pheno-
type, three densities (low 1k/cm2, medium 25k/cm2, and high 50k/
cm2) of young tenocytes were used.
While there is a minimal effect of Rac1 inactivation alone on the
young tenocyte phenotype in normoxic conditions (21% O2) (Fig-
ure 5b–e), we found that when young tenocytes expressed constitu-
tively active RhoA concomitant with pharmacologic Rac1
inactivation, there was 300‐fold increased collagen IIα1, and 700‐fold
increased collagen X expression (p < 0.001, Figure 5d,e). This effect
was not observed in collagen III (Figure 5c). Interestingly, RhoA inac-
tivity alone resulted in 300‐fold increase in collagen Iα2 and 100‐fold
increase in collagen III (p < 0.001, Figure 5b,c). These findings were
most significant in the medium cell density environment (25k/cm2)
and indicate a strong role in young tenocytes for coordinated Rac1
inactivity coupled with RhoA activity as being necessary and suffi-
cient for human tenocyte development of a fibrochondrocyte and
mineralized fibrochondrocyte phenotype, irrespective of oxygen ten-
sion and patient age.
As senescence increases in aged cells and could be a potential
confounding effect on our observations (Coppe et al., 2010), we cul-
tured young, young tendinotic, and aged tenocytes in hypoxic (1%
O2) and normoxic (21% O2) conditions, with or without the Rac1
inhibitor NSC23766, and harvested the cells for βgal senescence
assay and p16 expression (Figure 5f–r, Supporting Information Data
S5). Aged tenocytes demonstrate increased senescence compared to
young asymptomatic tenocytes and young tendinotic tenocytes in
normoxic as well as hypoxic conditions (p < 0.05, Figure 5f–r).
Hypoxia decreased senescence in young asymptomatic and aged
tenocytes (p < 0.05, Figure 5r). Immunoblot of p16 expression also
demonstrated decreased p16 in young asymptomatic when com-
pared to aged tenocytes, in hypoxic and normoxic conditions (Sup-
porting Information Data S5). However, there was insignificant
change in senescence and p16 expression in the presence of the
Rac1 inhibitor NSC23766 (Figure 5, Supporting Information Data
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S5). These findings suggest that the effect of Rac1/RhoA activity on
the human tenocyte phenotype is independent of senescence associ-
ated with p16 expression and acidic beta‐galactosidase activity.
2.6 | Rac1 inhibition in human tendon explants
recreates the aged diseased tendon phenotype
In order to investigate whether our hypothesis that Rac1 inhibition
in hypoxia underlies tenocyte development of a fibrochondrocyte
phenotype holds in a three‐dimensional tendon structure, we col-
lected tendons from young affected patients (Tendinotic) undergoing
tendon reconstruction, and young asymptomatic patients (Young)
undergoing revision amputation for mutilating hand injury according
to IRB‐approved protocols as previously, stripped the tendons of all
surrounding tenosynovium, and cultured them as explants in nor-
moxic (21% O2) or hypoxic (1% O2) conditions, in the absence or
presence of Rac1 inhibitor NSC23766 (Figure 6a–j), without tension.
In normoxic conditions, young tendinotic and young asymptomatic
tendon explants displayed slight rounding of nuclei but no significant
matrix metachromasia (Figure 6a,c), and expressed collagen 1α2 but
not collagen 2α1 or collagen X (Figure 6j,l). However, when treated
with NSC23766 in normoxic conditions, young tendinotic tendon
explants displayed significant matrix metachromasia (Figure 6b) calci-
fication (Figure 6b,j) and collagen X (Figure 6k), while asymptomatic
tendon explants displayed minimal nuclear rounding and matrix
metachromasia, with no calcification (Figure 6d,j). Interestingly, in
hypoxia, young asymptomatic tendon explants displayed significant
hypercellularity and mild nuclear rounding (Figure 6e), and when
treated with NSC23766, there was prominent nuclear rounding and
matrix metachromasia (Figure 6f), as well as a gradient of calcifica-
tion at the edges of the tendon explant (Figure 6g) prominent calcifi-
cation (Figure 6h,j) accompanied by expression of collagen 2α1,
collagen X, and HIF1α (Figure 6o). FTIR revealed minimal effects of
hypoxia and NSC inhibition on mature collagen ratios (Figure 6i), but
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F IGURE 7 Model of age‐dependent
tenocyte phenotype determination via
hypoxic Rac1 inhibition.
Microenvironmental cues including oxygen
and cell density determine the human
tenocyte phenotype. Hypoxia and low cell
density in young tenocytes (a) activate
Rac1 which inhibits RhoA, driving the
tenocyte phenotype and repressing
fibrochondrocyte and mineralized
fibrochondrocyte formation. In aged
tenocytes (b), hypoxia and low cell density
inhibit Rac1 activity, allowing RhoA
activation and formation of the
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significant increases in mineralization (Figure 6j). These findings sug-
gest that Rac1 inhibition of human hypoxic tenocytes not subjected
to tensile stress results in a fibrochondrocyte and mineralized fibro-
chondrocyte phenotype, even in a three‐dimensional environment.
3 | DISCUSSION
The clinical entity of tendinosis is prevalent, debilitating, and age‐re-
lated. Correlations between the histopathologic phenotype of tendi-
nosis—hyalinization and mineralization—and hypovascularity of
tendons have been classically described in human tendinosis and aged
tendon. The molecular mechanism responsible for the tenocyte phe-
notype changes in tendinosis, however, has heretofore been
unknown. In this study, we investigated one possible mechanism of
tendinosis development using immunohistochemical, biochemical, and
molecular biology techniques on human patient samples and cells. We
have discovered a novel relationship between hypoxia and inhibition
of Rac1 GTPase activity at low cell density in aged tenocytes, which
predisposes aged tenocytes to develop a fibrochondrocyte and miner-
alized fibrochondrocyte phenotype likely through RhoA disinhibition
(Figure 7a,b). Furthermore, young tenocytes require concomitant Rac1
inhibition and RhoA activation to develop the fibrochondrocyte phe-
notype (Figure 7a), a finding observed exclusively in hypoxia. Given
that tenocyte cell density affects Rac1/RhoA GTPase activity (Figure 3;
Supporting Information Data S3, S3A and S4) and Rac1/RhoA activity
mediates mechanical force transmission (Mui, Chen, & Assoian, 2016),
we believe that the effect of tenocyte cell density on Rac1/RhoA
activity as demonstrated here represents one way in which the teno-
cyte mechanical—in addition to oxygen—microenvironment effects
tendinosis development.
Although the anatomic blood supply to tendons is well studied,
the actual physiologic oxygen tension which supplies the tenocyte
microenvironment is unclear. Established oxygen concentrations in
mammalian tissues range from 1% to 7% in bone marrow and 1%–
5% in interstitial tissues (Fehrer et al., 2007). In vitro studies of teno-
cytes cultured at 2%–7% O2 reveal decreased sensitivity of total pro-
tein and collagen production to hypoxia than other cell types, effects
which are more pronounced at low cell density (Webster & Burry,
1982). Given the known effects of hypoxia and cell density on teno-
cyte phenotype maintenance (Yao et al., 2006; Zhang & Wang,
2018), the well‐documented decrease in vascularity of aged tendons
(Rothman & Parke, 1965) and our own empiric studies, we chose to
study human tenocytes isolated from aged and young individuals in
hypoxic (1% O2) and normoxic (21% O2) conditions. In vitro tenocyte
phenotype changes to fibrochondrocyte and mineralized fibrochon-
drocyte were dependent on hypoxia, and hypoxic tendon explants in
which Rac1 was inhibited also demonstrated the fibrochondrocyte
and mineralized fibrochondrocyte phenotype. Aged and young
patient tendinosis samples as well as hypoxic tendon explant culture
demonstrated increased HIF‐1α expression, which interestingly has
been associated with Rac1 activity in other systems (Hirota &
Semenza, 2001). Why hypoxia inhibits Rac1 activation in aged teno-
cytes at low cell density is unknown.
Interestingly, a similar pattern of tenocyte phenotype alteration
—to fibrochondrocyte and mineralized fibrochondrocyte—occurs
both at the embryonic and mature tendon‐bone insertion, termed
the attachment unit and enthesis, respectively (Zelzer, Blitz, Killian, &
Thomopoulos, 2015). In mice, the tendon‐bone attachment unit is
formed from GDF5 progenitors co‐expressing Sox9 and Scx, regu-
lated by the hedgehog (Hh) pathway (Dyment et al., 2015; Schwartz,
Long, & Thomopoulos, 2015). Interestingly, decreased muscle loading
increased the Hh‐responsive cell population, while ablation of the
Hh‐responsive cells decreased fibrocartilage mineralization (Schwartz
et al., 2015). The capacity for these progenitor cells to regenerate
the mature enthesis was lost after terminal differentiation to fibro-
chondrocytes, however (Schwartz, Galatz, & Thomopoulos, 2017).
While our studies were conducted using tenocytes isolated from
mature human patients, the phenotypes we have observed in tendi-
nosis are those that exist at the enthesis. Furthermore, given the
relationships reported between Hh and the Rho/Rac family of
GTPases, in particular the classic finding of increased Ihh signaling
and ColX expression in Rac1‐deficient mice (Wang et al., 2007), we
feel that our findings and model based on human patients and cells
are symbiotic to those findings described in other developmental
systems.
While we demonstrate a role for the Rho/Rac GTPases in tendi-
nosis development, many other mechanisms affect the increased
incidence of tendinosis with age. Aging results in increased matrix
metalloproteinase activity in tenocytes (Yu et al., 2013) which causes
decreased tendon strength (Dudhia et al., 2007). The mechanical
contractile properties of aged tendon have been demonstrated to be
age‐ and time‐dependent, thus affecting the mechanobiological envi-
ronment of tenocytes (Lavagnino et al., 2014). Finally, the inflamma-
tory component of tendinosis is incompletely understood, and
dramatically changes with aging with respect to cytokine and prosta-
glandin expression (Ferrucci & Fabbri, 2018; Millar, Murrell, &
McInnes, 2017). By correlating the roles of the oxygen and mechani-
cal environment, we believe our findings enhance the current under-
standing of tendinosis development, and propose a molecular
mechanism by which it occurs.
4 | MATERIALS AND METHODS
4.1 | Tendon preparation, surgical technique, and
explant culture
Human tendon was isolated from patients undergoing revision
amputation for traumatic hand injury using IRB‐approved protocols
(#13D.238). Young asymptomatic tendon (“Young,” 19–42 y) and
aged tendon (“Aged,” 65–81 years) were isolated from patients
excluding workman's compensation, diabetes, pregnancy, systemic
hormonal disorders or illness, revision surgery, and infection. Young
affected tendon (“Tendinosis,” 35–44 years) was isolated from
patients having had undergone repetitive stress injury presenting for
surgical reconstruction. Multiple 3‐cm‐long areas of finger flexor ten-
don were harvested, dissected thoroughly from surrounding
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tenosynovium, and digested for tenocyte isolation or kept whole for
explant culture. Aged tendinosis tissue was isolated from patients
(75–80 years) undergoing A1 pulley release for flexor tendinosis.
4.2 | Tenocyte isolation, cell culture, and FACS
analysis
Human tenocytes were isolated from tendon tissue according to
established protocols (Yao et al., 2006). In brief, tendon tissue was
cut into 2 × 2 mm pieces and digested in collagenase solution (Wor-
thington, collagenase type 2) in hg DMEM/Primocin (Invivogen), in
37°C incubator on shaker overnight. Digested tissue was filtered,
centrifuged, and the cell pellet resuspended in growth media (hg
DMEM, 10% pen/strep, L‐glutamine, primocin, 10% FBS (Gemini))
and plated at 5k cells/cm2. Tenocytes were maintained in normoxic
(21% O2, ThermoForma Series II) or hypoxic (1% O2, Ruskinn Invivo2
hypoxia workstation) conditions. Cell culture media was changed
weekly. Cells were passaged at 5k/cm2 after obtaining confluence
unless described otherwise. Average time to confluence was
3 weeks. Experiments were performed using tenocytes of early pas-
sage (less than or equal to passage 4).
For FACS analysis, tenocytes were trypsinized and incubated
with cell surface markers CD19, CD34, CD44, CD45, CD73, CD90,
and CD105 according to manufacturer's instructions (BioLegend) and
analyzed on FACS BD FACSCAlibur.
4.3 | Immunohistochemistry, immunofluorescence,
light microscopy stains, and FTIR
Human tendon surgical samples were fixed in 10% neutral buffered
formalin and subjected to routine processing and H&E staining. For
immunohistochemistry, 4‐um paraffin slides were deparaffinized in
Shandon Varistain Gemini ES Autostainer. Antigen retrieval was
performed with DAKO PTLink using Citrate Buffer (pH6.0) at 98˚C.
Primary immunostaining was performed using antibodies against col-
lagen 1α2 (gift from Dr. A. Fertala), collagen 2α1 (OriGene), collagen
X (Abcam), and HIF‐1α (Abcam). Biotinylated anti‐rabbit or anti‐
mouse (Vector Laboratories) secondary antibodies and ABC‐HRP
complexes (Vector Laboratories) were applied. The signals were
visualized using DAB substrate (DAKO) and counterstained with
Hematoxylin.
For immunofluorescence, slides were incubated with primary
antibodies: mouse monoclonal collagen 1α2, collagen 2α1, or colla-
gen 3 (Abcam) at 4°C overnight. All slides were developed using goat
anti‐mouse secondary antibody (Alexa Fluor) and DAPI to visualize
the nuclei. Specimens were photographed using a fluorescence
microscope (Eclipse E600, Nikon) equipped with a digital camera
(DSQilMc, Nikon).
Alizarin Red staining was performed using kit 8678 (ScienCell)
according to manufacturer's instructions, visualized using Nikon
Eclipse TS100, and photographed using HTC One camera. Quantita-
tion was performed according to manufacturer's instructions and
quantitated using Tecan Infinite M1000 platereader. Alizarin red and
alcian blue histopathologic stains were prepared and conducted
according to Histopathology Core protocol.
β‐galactosidase assay (Millipore) was performed according to
manufacturer's protocol.
FTIR was performed and analyzed according to standard proto-
cols (Hanifi et al., 2013) using PerkinElmer FTIR Spectrometer Fron-
tier/Spotlight 400. Human tendon surgical samples were fixed in
10% neutral buffered formalin and embedded in paraffin. Specimens
were sectioned at 5 μm thickness on low emissivity slides (low‐e,
Kevley Technologies, Chesterland, OH). Tendons were sectioned lon-
gitudinally, deparaffinized, and dehydrated prior to FTIR analysis.
FTIR data were acquired from tendon sections at 8‐cm−1 spectral
resolution and 25‐µm spatial resolution with 32 scans per pixel. To
calculate the relative amount of total protein to relative amount of
mature collagen total protein in tendon, ratios of maximum absor-
bance at 1,640 cm−1 (Amide I) to that at 1,338 cm−1 (Amide III) were
calculated. The same approach was undertaken to calculate relative
amount of mineral deposited in the tendon to that of mature colla-
gen. Ratios of maximum absorbance at 1,035 cm−1 for mineral con-
tent to that at 1,338 cm−1 (Amide III) were calculated.
4.4 | Protein isolation and immunoblot
Tenocytes or tendon tissue was lysed in RIPA lysis buffer (Santa
Cruz Biotech) and centrifuged; supernatant was loaded onto 12.5%
SDS‐PAGE gels and transferred according to well‐established proto-
cols. Antibodies to collagen Iα2 (rabbit polyclonal; gift of A. Fertala,
Thomas Jefferson University), collagen IIα1 (Millipore), collagen III
(Sigma), gapdh (Santa Cruz Biotech), RhoA (Santa Cruz Biotech), and
Rac1 (Millipore) were used. Blots were imaged using ProteinSimple
FluorChem E and quantitated using ImageJ software.
4.5 | Quantitative RT–PCR
RNA was isolated using TRIZOL according to manufacturer's instruc-
tions (ThermoFisher Scientific). cDNA was prepared using 1 μg RNA
and ecodry premix (Clontech). Quantitative RT–PCR was performed
using Applied Biosystems StepOne qRT–PCR and primers for GAPDH,
collagen Iα2, collagen IIα1, collagen 3, collagen X, scleraxis, and
tenomodulin according to previously published primer sequences (Ber-
tolo et al., 2012; Kyllonen et al., 2013; Wagenhauser et al., 2012).
PowerUp SYBR Green (Applied Bioscience) was used as mastermix. All
samples were run in duplicate. Data were prepared using ΔΔCt and
Microscoft Excel. Error reported is standard deviation from the mean.
4.6 | Rho/Rac GTPase biochemical assay
Tenocytes were lysed in RIPA lysis buffer (Santa Cruz Biotech) and
centrifuged, and supernatant added to PAK1‐GST beads for Rac1
activity assay (Millipore) or Rhotekin‐GST beads for RhoA activity
assay (Millipore), and assays performed according to manufacturer's
instructions. Assays were repeated in duplicate for each patient
sample.
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4.7 | Pharmacologic and adenoviral agents
Rac1 inhibitor NSC23766 was used at 50 μM according to manufac-
turer's instructions and IC50 reported in the literature (Millipore)
(Gao et al., 2004). ROCK inhibitor Y‐27632 was used at 10 μM
according to manufacturer's instructions (Millipore). For adenoviral
studies, constitutively active and dominant negative RhoA and Rac1
adenovirus were purchased, prepared, and titrated according to man-
ufacturer's instructions (CellBioLabs).
4.8 | Statistical analysis
qRT–PCR and Western blot quantitation data were analyzed using
ΔΔCT (qRT–PCR), Spearman's rho and subsequent regression analy-
sis as described (Maltenfort, 2015). qRT–PCR assays with two vari-
ables (drug, viral studies) were also assessed using ΔΔCT and
Student's paired t‐test. Error bars depict SEM.
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